---
schema_version: "secwatch.filing_event.v1"
accession: "0001062822-23-000002"
form_type: "8-K"
ticker: "LXRX"
cik: "0001062822"
company_name: "LEXICON PHARMACEUTICALS, INC."
filed_at: "2023-01-04T23:59:59+00:00"
generated_at: "2026-06-20T20:07:09.623549+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Lexicon draws $25M tranche under Oxford loan, issues warrant for 224,128 shares

## Summary
- Exercised option to draw second $25M tranche from Oxford Finance on Dec 30, 2022.
- Oxford received a warrant to purchase 224,128 shares at $1.95 per share, exercisable for 5 years.
- Warrant and underlying common stock issued in reliance on Section 4(2) exemption from registration.
- Proceeds from the tranche will support Lexicon's operations and development programs.

## SEC filing metadata
- accession: 0001062822-23-000002
- form_type: 8-K
- ticker: LXRX
- cik: 0001062822
- company_name: LEXICON PHARMACEUTICALS, INC.
- filed_at: 2023-01-04T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 2.03, 3.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1062822/000106282223000002/0001062822-23-000002-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1062822/000106282223000002/lxrx-20221230.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001062822-23-000002
- JSON: https://secwatch.observer/filing/0001062822-23-000002.json
- Plain text: https://secwatch.observer/filing/0001062822-23-000002.txt

## Key facts
- Debt Financings
  LEXICON PHARMACEUTICALS, INC. incurred credit facility of $25 million with Oxford Finance LLC.
  - Instrument: credit facility
  - Principal: $25 million
  - Counterparty: Oxford Finance LLC
  - Event: incurrence
  source text: On December 30, 2022, we exercised our option to draw the second $25 million tranche under our loan and security agreement with Oxford Finance LLC (“Oxford”) and the second tranche was funded on such date .
  evidence_url: https://www.sec.gov/Archives/edgar/data/1062822/000106282223000002/0001062822-23-000002-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.